Company Filing History:
Years Active: 2011-2020
Title: Morten Ruhwald: Innovator in Immunological Diagnostics
Introduction
Morten Ruhwald is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of immunological diagnostics, particularly in relation to tuberculosis and immune monitoring. With a total of 2 patents, his work has the potential to impact both human and veterinary medicine.
Latest Patents
Ruhwald's latest patents include innovative methods for skin testing for tuberculosis in immunocompromised individuals. This patent discloses the use of antigens for in vivo determination of the presence of Mycobacterium tuberculosis (Mtb) infection in individuals who are immunocompromised or co-infected with HIV. The invention also prepares a diagnostic reagent for skin testing, allowing for a robust assessment of Mtb infection in these vulnerable populations.
Another significant patent focuses on IP-10 based immunological monitoring. This invention relates to a method for measuring cell-mediated immune reactivity (CMI) in mammals, based on the production of IP-10. It further discloses an assay and a kit for measuring CMI to an antigen using whole blood or other suitable biological samples. The methods outlined in this patent are useful in therapeutic and diagnostic protocols across human, livestock, veterinary, and wildlife applications.
Career Highlights
Throughout his career, Morten Ruhwald has worked with esteemed institutions such as Hvidovre Hospital and Statens Serum Institut. His experience in these organizations has contributed to his expertise in immunology and diagnostics.
Collaborations
Ruhwald has collaborated with notable colleagues, including Pernille Ravn and Jesper Eugen-Olsen. These partnerships have likely enhanced his research and development efforts in the field of immunological diagnostics.
Conclusion
Morten Ruhwald's innovative work in immunological diagnostics, particularly in relation to tuberculosis and immune monitoring, showcases his commitment to advancing medical science. His patents reflect a dedication to improving diagnostic methods for vulnerable populations.